Inovio Pharmaceuticals Inc. (NASDAQ: INO)
$10.83
-0.3000 ( -2.70% ) 97.0K
Inovio Pharmaceuticals Inc is a United States-based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Market Data
Open
$10.83
Previous close
$11.13
Volume
97.0K
Market cap
$280.61M
Day range
$10.71 - $11.32
52 week range
$3.89 - $14.75
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | May 13, 2024 |
4 | Insider transactions | 1 | May 13, 2024 |
10-q | Quarterly Reports | 68 | May 13, 2024 |
8-k | 8K-related | 15 | May 13, 2024 |
8-k | 8K-related | 18 | Apr 17, 2024 |
ars | Annual reports | 1 | Apr 15, 2024 |
def | Proxies and info statements | 22 | Apr 11, 2024 |
10-k | Annual reports | 103 | Mar 06, 2024 |
4 | Insider transactions | 1 | Feb 28, 2024 |
4 | Insider transactions | 1 | Feb 28, 2024 |